management for residual disease in tnbc after chemo-immunotherapy
Published 4 months ago • 159 plays • Length 0:37Download video MP4
Download video MP3
Similar videos
-
17:08
hormone positive breast cancer algorithm - oncbrothers (rohit & rahul gosain) w/ dr. stephanie graff
-
16:56
tnbc sabcs 2022 highlights - oncbrothers (rohit and rahul gosain) with dr. maryam lustberg
-
4:28
for residual tnbc post-chemo, capecitabine should be offered
-
18:38
how to treat triple negative breast cancer | dr. ruth o'regan chair & dr. anna weiss
-
16:09
triple negative breast cancer algorithm - oncbrothers (rohit & rahul gosain) w/ dr. shipra gandhi
-
16:46
her2 breast cancer algorithm - oncbrothers (rohit & rahul gosain) w/ dr. paolo tarantino
-
0:43
management of residual disease in triple negative breast cancer
-
14:04
her2 positive breast cancer algorithm - oncbrothers (rohit & rahul gosain) w/ dr. erika hamilton
-
19:43
upper gastrointestinal cancer algorithm - oncbrothers (rohit & rahul gosain) w/ dr. rutika mehta
-
17:14
sabcs 2023 breast cancer highlights – nsabp b-51, idea update, icaro, keynote 522 update
-
20:52
colon cancer algorithm discussion with oncology brothers (rohit & rahul gosain) and dr. cathy eng
-
43:14
updates in systemic therapy for breast cancer 2/8/23
-
4:01
capecitabine remains the adjuvant standard of care for tnbc with residual disease | ingrid mayer
-
5:47
the meaning of residual disease in breast cancer
-
2:53
managing residual disease after neoadjuvant therapy in breast cancer
-
59:45
what's new in screening and treatment for lobular breast cancer
-
4:32
residual cancer burden in tnbc patients receiving neoadjuvant chemotherapy
-
1:16
tackling residual disease in breast cancer
-
2:30
highlighting a subset of tnbc for targeted therapy